ClinicalTrials.govpublic full text
Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)
advanced breast cancer, abemaciclib, hormone-receptor-positive (hr+), human-epidermal-growth-factor-negative (her2-), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 868305
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.